Max Healthcare Institute Limited announces Q2 2026 financials and key approvals
Max Healthcare Institute Ltd · Healthcare Services
What the filing says
- Approved unaudited standalone and consolidated financial results for quarter and half-year ended September 30, 2026
- Approved ₹93 crore capex for expansion of Max Super Speciality Hospital, Sector-128, Noida, operated by wholly-owned subsidiary Crosslay Remedies Limited
- Approved ₹97 crore capex for additional floors at Max Super Speciality Hospital, Vaishali, also operated by Crosslay Remedies Limited; appointed Dr. Dharmender Kumar as Director & Chief - Public Affairs from November 1, 2026
Why it's rated notable: the year-on-year change is 16% (10% to 20% for adverse news)
Original filing
Results - Financial Results For The Quarter And Half Year Ended September 30, 2026
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Max Healthcare Institute Ltd
- Capex / expansionNotable· Adverse for the businessMax Healthcare Institute Limited announces Q2 2026 results and expansion plans
Other financial results filings this fortnight
- Juniper Green Energy Limited announces unaudited Q2 and H1 FY2027 financial results
- Andhra Paper Limited reports Q2 and H1 FY 2027 unaudited financial results
- Advait Energy Transitions approves Sept 2026 quarter results and AURA stake purchase
- Medi Assist Healthcare Services Limited approves results and share buyback
- RattanIndia Power approves unaudited Q2 and H1 results to September 30, 2026
- Network18 Media & Investments Ltd reports Q2 & H1 FY2026 unaudited financial results
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.